Regional Program in Collaboration with Moffitt Cancer Center
Saturday, December 7, 2013
Tampa Marriott Waterside Hotel and Marina
Tampa, FL
Presentations included allotted time for Audience Response System (ARS) assisted audience interaction as well as general question and answer time. |
|
7:00 am - 8:00 am | Registration |
7:00 am - 8:00 am | Continental Breakfast |
8:00 am - 8:10 am | Welcome and Introductions James J. Mulé, PhD - Moffitt Cancer Center |
Principles of Tumor Immunology and Immunotherapy of Melanoma and Other Solid Tumors |
|
8:10 am - 8:35 am | Immunology 101 for the Non-Immunologist Kenneth L. Wright, PhD - Moffitt Cancer Center |
8:35 am - 9:00 am | Interferon: Indications and Clinical Management in Melanoma Vernon K. Sondak, MD - Moffitt Cancer Center |
9:00 am - 9:25 am | Interleukin-2 and Related Cytokines: Indications and Clinical Management Geoffrey T. Gibney, MD - Moffitt Cancer Center |
9:25 am - 9:40 am | Break |
9:40 am - 10:15 am | Ipilimumab in Melanoma: Indications and Clinical Management Ragini Kudchadkar, MD - Moffitt Cancer Center |
10:15 am - 10:50 am | Vaccines and Other Forms of Immunotherapy for Breast Cancer Keith L. Knutson, PhD - Vaccine & Gene Therapy Institute of Florida |
10:50 am - 11:25 am | Vaccines as Immunotherapy for Other Solid Tumors Duane A. Mitchell, MD, PhD - University of Florida |
11:25 am - 11:50 am | Panel Discussion |
11:50 am - 12:45 pm | Lunch |
Emerging Drugs and Concepts in Tumor Immunotherapy |
|
12:45 pm - 1:20 pm | The PD-1/PD-L1 Pathway as a Target in Tumor Immunotherapy Jeffrey S. Weber, MD, PhD - Moffitt Cancer Center |
1:20 pm - 1:55 pm | The Emerging Role of Combination Tumor Immunotherapy Gregory K. Pennock, MD - MD Anderson Cancer Center Orlando |
1:55 pm - 2:30 pm | New Tumor Immunotherapy Strategies on the Horizon Amod A. Sarnaik, MD - Moffitt Cancer Center |
2:30 pm - 2:55 pm | Panel Discussion |
2:55 pm - 3:00 pm | Closing Remarks Vernon K. Sondak, MD - Moffitt Cancer Center |
All presentations are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.